ESKEN LIMITED

Regulatory Filings • Jun 5, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2666Q

Stobart Group Limited

05 June 2018

5 June 2018

STOBART GROUP LIMITED

('Stobart Group' or 'the Company')

Shareholder requisition

The Company announces that it has received a requisition from shareholders holding in excess of 33% of the Company's voting capital to nominate Philip Day to be elected as a Director of the Company either at its forthcoming Annual General Meeting or at a subsequently convened general meeting and to invite the Board to nominate him as Chairman.  The shareholders comprise Andrew Tinkler, Executive Director, funds acting through Woodford Investment Management Limited and Allan Jenkinson.

The Board, through its Nomination Committee, had separately identified in the ordinary course an excellent female candidate to replace John Garbutt who is standing down at the AGM.  This candidature has been placed on hold pending the outcome of the AGM.

The Board will convene a general meeting of the Company in accordance with its Articles of Incorporation in due course to put Mr Day's election as a director to a shareholder vote.  In addition, the Nomination Committee will consider Mr Day's candidature and will advise shareholders in due course of its recommendation in relation to board appointments. 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 956/2014.

ENDS

Enquiries:

Redleaf Communications                                            

Robin Tozer                                                                     

Charles Ansdell

+44 203 757 6880

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCFIMBTMBBMTLP